Clinical Study
Comprehensive Evaluation of Personal, Clinical, and Radiation Dosimetric Parameters for Acute Skin Reaction during Whole Breast Radiotherapy
Table 3
Chi-square tests for skin toxicity (linear-to-linear correlation).
| | | Axilla () | Inferior fold () | | | 1 | 2 | 3 | 4 | 5 | 6 | ( value) value | 1 | 2 | 3 | 4 | 5 | 6 | ( value) value |
| Age | 50≤ | 3 | 19 | 21 | 13 | 33 | 3 | (2.908) | 15 | 21 | 9 | 14 | 29 | 4 | (6.355) | 50> | 0 | 11 | 8 | 9 | 5 | 0 | 0.088 | 9 | 11 | 3 | 6 | 4 | 0 | 0.012 |
| Laterality | Right | 2 | 18 | 12 | 11 | 23 | 1 | (0.000) | 15 | 10 | 10 | 12 | 19 | 1 | (0.143) | Left | 1 | 12 | 17 | 11 | 15 | 2 | 0.994 | 9 | 22 | 2 | 8 | 14 | 3 | 0.705 |
| T-stage | is, 1 | 3 | 20 | 23 | 17 | 26 | 2 | (0.179) | 14 | 25 | 12 | 15 | 23 | 2 | (0.013) | 2 | 0 | 10 | 6 | 5 | 12 | 1 | 0.673 | 10 | 7 | 0 | 5 | 10 | 2 | 0.910 |
| N-stage | 0 | 3 | 24 | 25 | 20 | 31 | 3 | (0.024) | 19 | 29 | 11 | 16 | 28 | 3 | (0.039) | 1 | 0 | 6 | 4 | 2 | 7 | 0 | 0.877 | 5 | 3 | 1 | 4 | 5 | 1 | 0.843 |
| Axillary dissection | No, SLND | 2 | 22 | 20 | 16 | 27 | 2 | (0.007) | 17 | 24 | 10 | 12 | 22 | 4 | (0.122) | ALND | 1 | 8 | 9 | 6 | 11 | 1 | 0.932 | 7 | 8 | 2 | 8 | 11 | 0 | 0.726 |
| Chemotherapy | No | 3 | 12 | 9 | 11 | 12 | 0 | (1.961) | 12 | 12 | 4 | 7 | 11 | 1 | (1.564) | Yes | 0 | 18 | 20 | 11 | 26 | 3 | 0.161 | 12 | 20 | 8 | 13 | 22 | 3 | 0.211 |
| Hormonal therapy | No | 0 | 9 | 6 | 4 | 10 | 3 | (0.872) | 6 | 6 | 4 | 5 | 8 | 3 | (0.908) | Yes | 3 | 21 | 23 | 18 | 28 | 0 | 0.350 | 18 | 26 | 8 | 15 | 25 | 1 | 0.341 |
|
|
SLND: sentinel lymph node dissection; ‡ALND: axillary lymph node dissection; parameter with ; parameter with .
|